
    
      Sequential crossover using tracer 11C-desmethylloperamide, a substrate for brain
      P-glycoprotein, and positron emission tomography (PET), administered after nothing (control),
      oral ritonavir (3d), and oral efavirenz (14d) with washout in between
    
  